409 results on '"Listing, Joachim"'
Search Results
2. Implementing an automated monitoring process in a digital, longitudinal observational cohort study
3. Associations de patients atteints de spondylarthrite ankylosante – quelles différences entre membres et non-membres ?
4. Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort
5. Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis
6. Ankylosing spondylitis self-help organisations – do members differ from non-members?
7. Vergleich des Effekts einer konsequenten Behandlung mit NSAIDs in Kombination mit einer Anti-TNF-Therapie im Vergleich zu einer alleinigen Anti-TNF-Therapie auf das Fortschreiten von strukturellen Schäden an der Wirbelsäule über einen Zeitraum von zwei Jahre bei Patienten mit ankylosierender Spondylitis (CONSUL) – eine offene, randomisierte, kontrollierte, multizentrische Studie
8. The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
9. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
10. The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)
11. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
12. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
13. Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab
14. Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT
15. The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers
16. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis
17. Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial
18. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
19. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
20. Additional file 1 of Implementing an automated monitoring process in a digital, longitudinal observational cohort study
21. The Natural Course of Radiographic Progression in Ankylosing Spondylitis: Differences Between Genders and Appearance of Characteristic Radiographic Features
22. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
23. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
24. The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
25. Risk of Herpes Zoster in patients with rheumatoid arthritis treated with Anti-TNF-[alfa] agents
26. Implementing an Automated Monitoring Process in a Digital, Longitudinal Observational Cohort Study
27. Impact of biologic therapy on functional status in patients with rheumatoid arthritis—a meta-analysis
28. Canakinumab zur Behandlung von adultem Still Syndrom (AOSD): eine Prüfer-initiierte, multizentrische, plazebokontrollierte Studie (CONSIDER)
29. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC)
30. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
31. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial
32. One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare
33. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
34. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
35. Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial
36. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
37. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis
38. Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years—early clinical response predicts long-term outcome
39. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis
40. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
41. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
42. Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers
43. Response to: ‘Changing the outcome measures, changing the results? The urgent need of a specific Disease Activity Score to adult-onset Still’s disease’ by Ruscitti et al
44. Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
45. Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
46. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
47. Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
48. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
49. The Early Disease Stage in Axial Spondylarthritis: Results From the German Spondyloarthritis Inception Cohorta
50. Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.